HU222185B1 - Szaruhártya-rátétek - Google Patents
Szaruhártya-rátétek Download PDFInfo
- Publication number
- HU222185B1 HU222185B1 HU9601345A HU9601345A HU222185B1 HU 222185 B1 HU222185 B1 HU 222185B1 HU 9601345 A HU9601345 A HU 9601345A HU 9601345 A HU9601345 A HU 9601345A HU 222185 B1 HU222185 B1 HU 222185B1
- Authority
- HU
- Hungary
- Prior art keywords
- corneal
- tissue
- serum
- cells
- collar
- Prior art date
Links
- 230000003287 optical effect Effects 0.000 claims abstract description 45
- 239000000463 material Substances 0.000 claims abstract description 34
- 210000004087 cornea Anatomy 0.000 claims abstract description 31
- 239000012530 fluid Substances 0.000 claims abstract description 27
- 238000002513 implantation Methods 0.000 claims abstract description 12
- 230000004304 visual acuity Effects 0.000 claims abstract description 7
- 241000124008 Mammalia Species 0.000 claims abstract description 3
- 210000001519 tissue Anatomy 0.000 claims description 76
- 239000011148 porous material Substances 0.000 claims description 42
- 210000000981 epithelium Anatomy 0.000 claims description 18
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 230000004438 eyesight Effects 0.000 claims description 3
- 230000008467 tissue growth Effects 0.000 claims description 3
- 239000000560 biocompatible material Substances 0.000 claims 1
- 230000037361 pathway Effects 0.000 claims 1
- 230000002629 repopulating effect Effects 0.000 claims 1
- 230000012010 growth Effects 0.000 abstract description 19
- 230000035515 penetration Effects 0.000 abstract description 4
- 230000003902 lesion Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 93
- 239000012528 membrane Substances 0.000 description 82
- 210000004379 membrane Anatomy 0.000 description 78
- 210000002966 serum Anatomy 0.000 description 68
- 108010067306 Fibronectins Proteins 0.000 description 49
- 102000016359 Fibronectins Human genes 0.000 description 49
- 210000002919 epithelial cell Anatomy 0.000 description 48
- 108010031318 Vitronectin Proteins 0.000 description 35
- 102100035140 Vitronectin Human genes 0.000 description 35
- 239000007943 implant Substances 0.000 description 35
- 238000002474 experimental method Methods 0.000 description 27
- 238000000034 method Methods 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 21
- 239000004793 Polystyrene Substances 0.000 description 20
- 229920002223 polystyrene Polymers 0.000 description 20
- 239000004017 serum-free culture medium Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 238000011282 treatment Methods 0.000 description 16
- 230000010261 cell growth Effects 0.000 description 15
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 14
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 14
- 241000282326 Felis catus Species 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 14
- 210000002744 extracellular matrix Anatomy 0.000 description 14
- 239000010410 layer Substances 0.000 description 14
- 230000005012 migration Effects 0.000 description 14
- 238000013508 migration Methods 0.000 description 14
- 229920000515 polycarbonate Polymers 0.000 description 14
- 239000004417 polycarbonate Substances 0.000 description 14
- 229920000642 polymer Polymers 0.000 description 14
- 241000283690 Bos taurus Species 0.000 description 13
- 235000015097 nutrients Nutrition 0.000 description 12
- 108010085895 Laminin Proteins 0.000 description 11
- 102000007547 Laminin Human genes 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 238000001356 surgical procedure Methods 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 9
- 239000000017 hydrogel Substances 0.000 description 9
- 102000012422 Collagen Type I Human genes 0.000 description 8
- 108010022452 Collagen Type I Proteins 0.000 description 8
- 206010029113 Neovascularisation Diseases 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
- 210000001161 mammalian embryo Anatomy 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 210000003038 endothelium Anatomy 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000012679 serum free medium Substances 0.000 description 6
- 230000001228 trophic effect Effects 0.000 description 6
- 230000001464 adherent effect Effects 0.000 description 5
- 230000021164 cell adhesion Effects 0.000 description 5
- 210000003560 epithelium corneal Anatomy 0.000 description 5
- 230000007717 exclusion Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 101150116295 CAT2 gene Proteins 0.000 description 4
- 101100326920 Caenorhabditis elegans ctl-1 gene Proteins 0.000 description 4
- 101100126846 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) katG gene Proteins 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 201000007717 corneal ulcer Diseases 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 101100005280 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cat-3 gene Proteins 0.000 description 3
- 206010064996 Ulcerative keratitis Diseases 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000012888 bovine serum Substances 0.000 description 3
- 210000004045 bowman membrane Anatomy 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 210000002555 descemet membrane Anatomy 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000834 fixative Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 239000002198 insoluble material Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000031852 maintenance of location in cell Effects 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229960000907 methylthioninium chloride Drugs 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000001747 pupil Anatomy 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000004266 Collagen Type IV Human genes 0.000 description 2
- 108010042086 Collagen Type IV Proteins 0.000 description 2
- 206010055665 Corneal neovascularisation Diseases 0.000 description 2
- 102400001368 Epidermal growth factor Human genes 0.000 description 2
- 101800003838 Epidermal growth factor Proteins 0.000 description 2
- 206010015548 Euthanasia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940096422 collagen type i Drugs 0.000 description 2
- 201000000159 corneal neovascularization Diseases 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 229940116977 epidermal growth factor Drugs 0.000 description 2
- 210000005081 epithelial layer Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 101100392078 Caenorhabditis elegans cat-4 gene Proteins 0.000 description 1
- 101100494773 Caenorhabditis elegans ctl-2 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 208000030275 Chondronectin Diseases 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 101100112369 Fasciola hepatica Cat-1 gene Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 101100005271 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cat-1 gene Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 102000002938 Thrombospondin Human genes 0.000 description 1
- 108060008245 Thrombospondin Proteins 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- CVQODEWAPZVVBU-UHFFFAOYSA-N XMC Chemical compound CNC(=O)OC1=CC(C)=CC(C)=C1 CVQODEWAPZVVBU-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940096423 bovine collagen type i Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000002701 cell growth assay Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 210000003683 corneal stroma Anatomy 0.000 description 1
- 230000004453 corneal transparency Effects 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 229920006240 drawn fiber Polymers 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000013628 high molecular weight specie Substances 0.000 description 1
- 108700020610 human chondronectin Proteins 0.000 description 1
- 102000043667 human chondronectin Human genes 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- -1 poly (1-octene-1,8-diyl) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920003245 polyoctenamer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000032954 positive regulation of cell adhesion Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/145—Corneal inlays, onlays, or lenses for refractive correction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/142—Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Landscapes
- Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Catalysts (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPM254993 | 1993-11-19 | ||
| PCT/EP1994/003680 WO1995013764A1 (en) | 1993-11-19 | 1994-11-09 | Corneal onlays |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9601345D0 HU9601345D0 (en) | 1996-07-29 |
| HUT74277A HUT74277A (en) | 1996-11-28 |
| HU222185B1 true HU222185B1 (hu) | 2003-06-28 |
Family
ID=3777369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9601345A HU222185B1 (hu) | 1993-11-19 | 1994-11-09 | Szaruhártya-rátétek |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5713957A (OSRAM) |
| EP (1) | EP0729323B1 (OSRAM) |
| JP (1) | JPH09504706A (OSRAM) |
| KR (1) | KR100355168B1 (OSRAM) |
| CN (1) | CN1135168A (OSRAM) |
| AT (1) | ATE168879T1 (OSRAM) |
| CZ (1) | CZ286070B6 (OSRAM) |
| DE (1) | DE69412125T2 (OSRAM) |
| DK (1) | DK0729323T3 (OSRAM) |
| ES (1) | ES2122345T3 (OSRAM) |
| FI (1) | FI962094A7 (OSRAM) |
| HU (1) | HU222185B1 (OSRAM) |
| IL (1) | IL111578A (OSRAM) |
| NO (1) | NO306805B1 (OSRAM) |
| NZ (1) | NZ275119A (OSRAM) |
| PL (1) | PL177096B1 (OSRAM) |
| SG (1) | SG45284A1 (OSRAM) |
| TW (1) | TW257671B (OSRAM) |
| WO (1) | WO1995013764A1 (OSRAM) |
| ZA (1) | ZA949170B (OSRAM) |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090069817A1 (en) * | 1995-10-20 | 2009-03-12 | Acufocus, Inc. | Intrastromal corneal modification |
| US20050143717A1 (en) * | 2001-04-27 | 2005-06-30 | Peyman Gholam A. | Method of treatment of refractive errors using subepithelial or intrastromal corneal inlay with bonding coating |
| US6361560B1 (en) * | 1998-12-23 | 2002-03-26 | Anamed, Inc. | Corneal implant and method of manufacture |
| WO2000052516A2 (en) * | 1999-03-01 | 2000-09-08 | Boston Innovative Optics, Inc. | System and method for increasing the depth of focus of the human eye |
| GB0016008D0 (en) * | 2000-06-29 | 2000-08-23 | Nokia Networks Oy | Capacity changes in transceiver apparatus |
| US6544286B1 (en) * | 2000-07-18 | 2003-04-08 | Tissue Engineering Refraction, Inc. | Pre-fabricated corneal tissue lens method of corneal overlay to correct vision |
| AR030341A1 (es) * | 2000-08-14 | 2003-08-20 | Novartis Ag | Articulos biomedicos moldeados |
| US8668735B2 (en) | 2000-09-12 | 2014-03-11 | Revision Optics, Inc. | Corneal implant storage and delivery devices |
| WO2002021965A1 (en) | 2000-09-12 | 2002-03-21 | Anamed, Inc. | System for packaging and handling an implant and method of use |
| WO2003096876A2 (en) * | 2001-04-01 | 2003-11-27 | Sommer Phillipe L | Continuously operational diagnostic device |
| US20050182488A1 (en) * | 2001-04-27 | 2005-08-18 | Peyman Gholam A. | Implant and method for altering the refractive properties of the eye |
| US20050222679A1 (en) * | 2001-04-27 | 2005-10-06 | Peyman Gholam A | Bifocal implant and method for altering the refractive properties of the eye |
| US20050182489A1 (en) * | 2001-04-27 | 2005-08-18 | Peyman Gholam A. | Intraocular lens adapted for adjustment via laser after implantation |
| GB0121168D0 (en) * | 2001-08-31 | 2001-10-24 | Duckworth & Kent Ltd | Ophthalmic devices and procedures |
| KR20030032420A (ko) * | 2001-10-18 | 2003-04-26 | 한국과학기술연구원 | 손상된 안구 조직의 재생을 위한 생분해성 고분자로제조된 다공성 지지체 |
| AU2003207603B2 (en) * | 2002-01-17 | 2008-04-03 | Edward Perez | Methods for producing epithelial flaps on the cornea and for placement of ocular devices and lenses beneath an epithelial flap or membrane, epithelial delaminating devices, and structures of epithelium and ocular devices and lenses |
| US7364674B1 (en) * | 2002-07-23 | 2008-04-29 | Advanced Optical Technologies, Inc. | Corneal implants produced by irradiation of polymer films |
| EP1549255A4 (en) | 2002-09-13 | 2007-12-19 | Coopervision Inc | DEVICES AND METHOD FOR IMPROVING THE SEA THICKNESS |
| DE60223582T2 (de) * | 2002-12-24 | 2008-09-04 | Medical Technology Transfer Holding B.V. | Kosmetisches Augenimplantat |
| US7628810B2 (en) * | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
| US20050046794A1 (en) * | 2003-06-17 | 2005-03-03 | Silvestrini Thomas A. | Method and apparatus for aligning a mask with the visual axis of an eye |
| DE102004002990A1 (de) * | 2004-01-21 | 2005-08-18 | Robert Dr. Simmoteit | Material und Verfahren zum Stoffaustausch und Stofftransfer |
| EP1713440A4 (en) | 2004-01-23 | 2009-10-28 | California Inst Of Techn | GENETIC GENE PROTEINS, AND METHODS OF MAKING AND USING THE SAME |
| US10835371B2 (en) | 2004-04-30 | 2020-11-17 | Rvo 2.0, Inc. | Small diameter corneal inlay methods |
| CN1972643A (zh) * | 2004-05-20 | 2007-05-30 | 库柏维景公司 | 用于提高视力的角膜覆盖物和波前像差矫正 |
| WO2006019893A2 (en) * | 2004-07-15 | 2006-02-23 | Coopervision, Inc. | Intrastromal devices and method for improving vision |
| EP1791499A4 (en) * | 2004-08-13 | 2011-08-17 | Ottawa Health Research Inst | THE POWER TO IMPROVE OPHTHALMIC DEVICES AND RELEVANT PROCEDURES AND COMPOSITIONS |
| WO2006047534A1 (en) * | 2004-10-22 | 2006-05-04 | Acufocus | System and method for aligning an optic with an axis of an eye |
| US20060113054A1 (en) * | 2004-12-01 | 2006-06-01 | Silvestrini Thomas A | Method of making an ocular implant |
| US7491350B2 (en) * | 2004-12-01 | 2009-02-17 | Acufocus, Inc. | Method of making an ocular implant |
| US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
| US7976577B2 (en) * | 2005-04-14 | 2011-07-12 | Acufocus, Inc. | Corneal optic formed of degradation resistant polymer |
| US20060235428A1 (en) * | 2005-04-14 | 2006-10-19 | Silvestrini Thomas A | Ocular inlay with locator |
| AU2006202209B2 (en) * | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
| ES2400916T3 (es) * | 2005-06-08 | 2013-04-15 | Janssen Biotech, Inc. | Una terapia celular para degeneración ocular |
| TW200740416A (en) * | 2006-02-08 | 2007-11-01 | Coopervision Inc | Corneal onlays and related methods |
| US10555805B2 (en) | 2006-02-24 | 2020-02-11 | Rvo 2.0, Inc. | Anterior corneal shapes and methods of providing the shapes |
| US7883520B2 (en) * | 2006-04-10 | 2011-02-08 | Forsight Labs, Llc | Corneal epithelial pocket formation systems, components and methods |
| US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
| US20080305320A1 (en) * | 2007-03-02 | 2008-12-11 | Lucien Laude | Nanoscale surface activation of silicone via laser processing |
| WO2008143733A2 (en) * | 2007-03-02 | 2008-11-27 | Dohney Eye Institute | Biocompatible implants and methods of making and attaching the same |
| US8162953B2 (en) | 2007-03-28 | 2012-04-24 | Revision Optics, Inc. | Insertion system for corneal implants |
| US9549848B2 (en) | 2007-03-28 | 2017-01-24 | Revision Optics, Inc. | Corneal implant inserters and methods of use |
| US9271828B2 (en) | 2007-03-28 | 2016-03-01 | Revision Optics, Inc. | Corneal implant retaining devices and methods of use |
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| EP2610336A1 (en) | 2007-07-31 | 2013-07-03 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| MX2010005805A (es) | 2007-11-27 | 2010-06-09 | Lifescan Inc | Diferenciacion de celulas madre embrionarias humanas. |
| MX2010009251A (es) | 2008-02-21 | 2010-11-25 | Centocor Ortho Biotech Inc | Metodos, placas de superficie modificada y composiciones para la fijacion, el cultivo y el desprendimiento celular. |
| KR101683042B1 (ko) | 2008-04-04 | 2016-12-06 | 포사이트 비젼4, 인크. | 통증 관리 및 시력을 위한 치료 장치 |
| US9539143B2 (en) | 2008-04-04 | 2017-01-10 | Revision Optics, Inc. | Methods of correcting vision |
| JP2011516180A (ja) | 2008-04-04 | 2011-05-26 | レヴィジオン・オプティックス・インコーポレーテッド | 視力を矯正する角膜インレー設計および方法 |
| US9125735B2 (en) * | 2008-04-04 | 2015-09-08 | Forsight Labs, Llc | Method of correcting vision using corneal onlays |
| EP2296580A2 (en) * | 2008-04-04 | 2011-03-23 | Forsight Labs, Llc | Corneal onlay devices and methods |
| US20090306773A1 (en) * | 2008-06-04 | 2009-12-10 | Acufocus, Inc. | Opaque corneal insert for refractive correction |
| ES2697798T3 (es) | 2008-06-30 | 2019-01-28 | Janssen Biotech Inc | Diferenciación de células madre pluripotentes |
| US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
| US20100087920A1 (en) * | 2008-10-07 | 2010-04-08 | Forsight Labs, Llc | Corneal Onlay Lenses and Related Methods for Improving Vision of Presbyopic Patients |
| KR102025158B1 (ko) * | 2008-10-31 | 2019-09-25 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 췌장 내분비 계통으로의 분화 |
| RU2522001C2 (ru) | 2008-10-31 | 2014-07-10 | Сентокор Орто Байотек Инк. | Дифференцирование человеческих эмбриональных стволовых клеток в линию панкреатических эндокринных клеток |
| CA2744227C (en) * | 2008-11-20 | 2018-10-02 | Centocor Ortho Biotech Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
| JP2012509085A (ja) | 2008-11-20 | 2012-04-19 | ヤンセン バイオテツク，インコーポレーテツド | マイクロキャリア上での多能性幹細胞の培養 |
| DE202008015910U1 (de) | 2008-12-02 | 2009-03-05 | Lee, Kuo-Jen | Abnehmbarer Gepäckträger und Riegelvorrichtung eines Schlosses für ein Zweirad |
| KR101893021B1 (ko) * | 2009-07-20 | 2018-08-29 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| EP2456862A4 (en) | 2009-07-20 | 2013-02-27 | Janssen Biotech Inc | DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS |
| GB2485113B (en) | 2009-07-20 | 2016-12-28 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into cells of the pancreatic endoderm lineage |
| IN2012DN02153A (OSRAM) | 2009-08-13 | 2015-08-07 | Acufocus Inc | |
| RU2012108951A (ru) * | 2009-08-13 | 2013-09-20 | Акуфокус, Инк. | Скрытые интраокулярные имплантанты и линзы |
| US10004593B2 (en) | 2009-08-13 | 2018-06-26 | Acufocus, Inc. | Intraocular lens with elastic mask |
| WO2011050327A1 (en) | 2009-10-23 | 2011-04-28 | Forsight Labs Llc | Corneal denervation for treatment of ocular pain |
| US8591025B1 (en) | 2012-09-11 | 2013-11-26 | Nexisvision, Inc. | Eye covering and refractive correction methods for LASIK and other applications |
| WO2011050365A1 (en) | 2009-10-23 | 2011-04-28 | Forsight Labs, Llc | Conformable therapeutic shield for vision and pain |
| USD656526S1 (en) | 2009-11-10 | 2012-03-27 | Acufocus, Inc. | Ocular mask |
| KR101841271B1 (ko) | 2009-12-23 | 2018-03-22 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| DK2516625T3 (da) | 2009-12-23 | 2024-09-09 | Janssen Biotech Inc | Differentiering af humane embryonale stamceller |
| AU2011223900A1 (en) * | 2010-03-01 | 2012-09-13 | Janssen Biotech, Inc. | Methods for purifying cells derived from pluripotent stem cells |
| WO2011143299A2 (en) | 2010-05-12 | 2011-11-17 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells |
| SG187946A1 (en) | 2010-08-31 | 2013-03-28 | Janssen Biotech Inc | Differentiation of human embryonic stem cells |
| US9181528B2 (en) | 2010-08-31 | 2015-11-10 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells |
| ES2659393T3 (es) | 2010-08-31 | 2018-03-15 | Janssen Biotech, Inc. | Diferenciación de células madre embrionarias humanas |
| EP2632405A4 (en) | 2010-10-25 | 2016-02-24 | Nexisvision Inc | METHODS AND APPARATUSES FOR IDENTIFYING EYE RECOVERY ELEMENTS FOR SIGHT |
| CA2834295A1 (en) | 2011-04-28 | 2012-11-01 | Nexisvision, Inc. | Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability |
| WO2014210186A2 (en) | 2013-06-26 | 2014-12-31 | Nexisvision, Inc. | Contact lenses for refractive correction |
| US12044905B2 (en) | 2011-04-28 | 2024-07-23 | Journey1 Inc | Contact lenses for refractive correction |
| WO2013059813A1 (en) | 2011-10-21 | 2013-04-25 | Revision Optics, Inc. | Corneal implant storage and delivery devices |
| JP6046160B2 (ja) | 2011-12-02 | 2016-12-14 | アキュフォーカス・インコーポレーテッド | 選択的分光透過性を有する眼科マスク |
| KR102090751B1 (ko) | 2011-12-22 | 2020-03-19 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화 |
| EP2823037A4 (en) | 2012-03-07 | 2015-09-16 | Janssen Biotech Inc | DEFINED MEDIA FOR THE EXPANSION AND CARE OF PLURIPOTENTAL STEM CELLS |
| US9465233B2 (en) | 2012-04-20 | 2016-10-11 | Nexisvision, Inc. | Bimodular contact lenses |
| CN104335104B (zh) | 2012-04-20 | 2017-06-09 | 内希斯视觉股份有限公司 | 用于屈光矫正的接触透镜 |
| CN108034633B (zh) | 2012-06-08 | 2022-08-02 | 詹森生物科技公司 | 人胚胎干细胞向胰腺内分泌细胞的分化 |
| WO2014039495A1 (en) | 2012-09-05 | 2014-03-13 | University Of Miami | Novel keratoprosthesis, and system and method of corneal repair using same |
| MX2015008578A (es) | 2012-12-31 | 2015-09-07 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9. |
| US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| CN105705634A (zh) | 2012-12-31 | 2016-06-22 | 詹森生物科技公司 | 用于分化成胰腺内分泌细胞的人多能细胞的悬浮和群集 |
| RU2018116647A (ru) | 2012-12-31 | 2018-10-24 | Янссен Байотек, Инк. | Культивация эмбриональных стволовых клеток человека в воздушно-жидкостной зоне взаимодействия с целью их дифференцировки в панкреатические эндокринные клетки |
| US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
| US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
| US9341864B2 (en) | 2013-11-15 | 2016-05-17 | Nexisvision, Inc. | Contact lenses having a reinforcing scaffold |
| WO2015116559A1 (en) | 2014-01-29 | 2015-08-06 | Nexisvision, Inc. | Multifocal bimodulus contact lenses |
| CN117821369A (zh) | 2014-05-16 | 2024-04-05 | 詹森生物科技公司 | 小分子增强胰腺内分泌细胞中的mafa表达的用途 |
| WO2016081493A1 (en) | 2014-11-19 | 2016-05-26 | Acufocus, Inc. | Fracturable mask for treating presbyopia |
| WO2016144404A1 (en) | 2015-03-12 | 2016-09-15 | Revision Optics, Inc. | Methods of correcting vision |
| WO2017062316A1 (en) | 2015-10-05 | 2017-04-13 | Acufocus, Inc. | Methods of molding intraocular lenses |
| CA3005891C (en) | 2015-11-24 | 2023-12-12 | Acufocus, Inc. | Toric small aperture intraocular lens with extended depth of focus |
| SE1551698A1 (en) * | 2015-12-22 | 2017-05-02 | Rafat Mehrdad | A composite collagen hydrogel material, an implantable ophthalmic device comprising such material and methods of producing the composite collagen hydrogel material and the implantable ophthalmic device |
| MA45479A (fr) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen |
| US11364110B2 (en) | 2018-05-09 | 2022-06-21 | Acufocus, Inc. | Intraocular implant with removable optic |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4624669A (en) * | 1984-09-26 | 1986-11-25 | Surgidev Corporation | Corneal inlay with holes |
| US4621912A (en) * | 1985-02-14 | 1986-11-11 | Meyer Donald R | Foraminated optical contact lens |
| US4799931A (en) * | 1986-05-14 | 1989-01-24 | Lindstrom Richard L | Intracorneal lens |
| US5244799A (en) * | 1987-05-20 | 1993-09-14 | Anderson David M | Preparation of a polymeric hydrogel containing micropores and macropores for use as a cell culture substrate |
| US4911717A (en) * | 1987-06-18 | 1990-03-27 | Gaskill Iii Harold V | Intravasular artificial organ |
| US4810082A (en) * | 1987-07-01 | 1989-03-07 | Abel Robert Jr | Corneal onlay lens |
| US4865601A (en) * | 1987-07-07 | 1989-09-12 | Caldwell Delmar R | Intraocular prostheses |
| US4795462A (en) * | 1987-08-24 | 1989-01-03 | Grendahl Dennis T | Cylindrically segmented zone of focus artificial lens |
| US5171318A (en) * | 1987-11-09 | 1992-12-15 | Chiron Ophthalmics, Inc. | Treated corneal prosthetic device |
| US4851003A (en) * | 1988-01-05 | 1989-07-25 | Lindstrom Richard L | Corneal implant lens with fixation holes |
| US5192316A (en) * | 1988-02-16 | 1993-03-09 | Allergan, Inc. | Ocular device |
| US5108428A (en) * | 1988-03-02 | 1992-04-28 | Minnesota Mining And Manufacturing Company | Corneal implants and manufacture and use thereof |
| FR2630638B1 (fr) * | 1988-05-02 | 1997-08-08 | Inst Nat Sante Rech Med | Implant oculaire et son procede de preparation |
| JP2763776B2 (ja) * | 1988-05-27 | 1998-06-11 | 日本原子力研究所 | 細孔化コンタクトレンズの製造法 |
| US4994080A (en) * | 1988-07-15 | 1991-02-19 | Shepard Dennis D | Optical lens having at least one stenopaeic opening located in the central area thereof |
| CA2066660C (en) * | 1989-09-15 | 2002-07-30 | Cary Reich | Method for achieving epithelialization of synthetic lenses |
| GB8925302D0 (en) * | 1989-11-09 | 1989-12-28 | Nat Res Dev | Gas-permeable contact lens |
| WO1993014133A1 (en) * | 1992-01-15 | 1993-07-22 | Allergan, Inc. | Hydrogel compositions and structures made from same |
-
1994
- 1994-03-08 TW TW083101993A patent/TW257671B/zh active
- 1994-11-09 AT AT94931590T patent/ATE168879T1/de not_active IP Right Cessation
- 1994-11-09 KR KR1019960702637A patent/KR100355168B1/ko not_active Expired - Fee Related
- 1994-11-09 HU HU9601345A patent/HU222185B1/hu not_active IP Right Cessation
- 1994-11-09 CZ CZ19961429A patent/CZ286070B6/cs not_active IP Right Cessation
- 1994-11-09 DK DK94931590T patent/DK0729323T3/da active
- 1994-11-09 NZ NZ275119A patent/NZ275119A/en unknown
- 1994-11-09 US US08/646,287 patent/US5713957A/en not_active Expired - Lifetime
- 1994-11-09 SG SG1996002738A patent/SG45284A1/en unknown
- 1994-11-09 WO PCT/EP1994/003680 patent/WO1995013764A1/en not_active Ceased
- 1994-11-09 ES ES94931590T patent/ES2122345T3/es not_active Expired - Lifetime
- 1994-11-09 CN CN94194202A patent/CN1135168A/zh active Pending
- 1994-11-09 EP EP94931590A patent/EP0729323B1/en not_active Expired - Lifetime
- 1994-11-09 PL PL94314525A patent/PL177096B1/pl unknown
- 1994-11-09 JP JP7506621A patent/JPH09504706A/ja active Pending
- 1994-11-09 DE DE69412125T patent/DE69412125T2/de not_active Expired - Lifetime
- 1994-11-10 IL IL11157894A patent/IL111578A/xx active IP Right Grant
- 1994-11-18 ZA ZA949170A patent/ZA949170B/xx unknown
-
1996
- 1996-05-14 NO NO961980A patent/NO306805B1/no not_active IP Right Cessation
- 1996-05-17 FI FI962094A patent/FI962094A7/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW257671B (OSRAM) | 1995-09-21 |
| CZ142996A3 (en) | 1996-10-16 |
| IL111578A (en) | 1999-04-11 |
| KR960705513A (ko) | 1996-11-08 |
| NO961980L (no) | 1996-05-14 |
| PL314525A1 (en) | 1996-09-16 |
| US5713957A (en) | 1998-02-03 |
| IL111578A0 (en) | 1995-01-24 |
| HUT74277A (en) | 1996-11-28 |
| WO1995013764A1 (en) | 1995-05-26 |
| DE69412125D1 (de) | 1998-09-03 |
| ATE168879T1 (de) | 1998-08-15 |
| DE69412125T2 (de) | 1999-05-06 |
| ES2122345T3 (es) | 1998-12-16 |
| KR100355168B1 (ko) | 2005-04-06 |
| JPH09504706A (ja) | 1997-05-13 |
| NO961980D0 (no) | 1996-05-14 |
| FI962094A0 (fi) | 1996-05-17 |
| ZA949170B (en) | 1995-07-07 |
| HU9601345D0 (en) | 1996-07-29 |
| DK0729323T3 (da) | 1999-05-03 |
| SG45284A1 (en) | 1998-01-16 |
| EP0729323B1 (en) | 1998-07-29 |
| CN1135168A (zh) | 1996-11-06 |
| FI962094A7 (fi) | 1996-05-20 |
| NZ275119A (en) | 1997-10-24 |
| PL177096B1 (pl) | 1999-09-30 |
| EP0729323A1 (en) | 1996-09-04 |
| NO306805B1 (no) | 1999-12-27 |
| CZ286070B6 (cs) | 2000-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU222185B1 (hu) | Szaruhártya-rátétek | |
| US10434219B2 (en) | Method of treatment using corneal epithelium forming cell sheets | |
| US5108428A (en) | Corneal implants and manufacture and use thereof | |
| US6045791A (en) | Retinal pigment epithelium transplantation | |
| US5139518A (en) | Methods employed in replacement of the corneal endothelium | |
| EP1776148B1 (en) | Ophthalmic devices and related methods and compositions | |
| Mohay et al. | Transplantation of corneal endothelial cells using a cell carrier device | |
| US20100028407A1 (en) | Layered bio-adhesive compositions and uses thereof | |
| US10052411B2 (en) | Methods of treating corneal related diseases by corneal endothelial preparation which enables cells to grow in vivo | |
| EP2755598A1 (en) | Fabrication of gelatin hydrogel sheet for the transplantation of corneal endothelium | |
| CN101629162B (zh) | 组织工程细胞片及其制备方法 | |
| CA2174967C (en) | Corneal onlays | |
| GB2250442A (en) | Ocular implant | |
| IL107498A (en) | Epithelium graft to retinal pigment | |
| WO2005075002A1 (ja) | 医療用材料及びその製造方法 | |
| Leibowitz et al. | Progress in the development of a synthetic cornea | |
| JP4874514B2 (ja) | 上皮系細胞の重層化培養方法、それから得られる重層化上皮系細胞シート及びその利用方法 | |
| Dupont et al. | Biocompatibility of human collagen type IV intracorneal implants | |
| AU682907B2 (en) | Corneal onlays | |
| CN109464705B (zh) | 一种rpe细胞片及其应用和制备方法 | |
| US20050214345A1 (en) | Artificial biocompatible material as a support for cells in a retinal implant | |
| CA2161659C (en) | Retinal pigment epithelium transplantation | |
| Huang | Corneal tissue engineering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DGB9 | Succession in title of applicant |
Owner name: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR Owner name: NOVARTIS AG, CH |
|
| HFG4 | Patent granted, date of granting |
Effective date: 20030319 |
|
| HMM4 | Cancellation of final prot. due to non-payment of fee | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |